Stay informed with the latest litigation news. Explore now

IP Verse

Par Pharmaceutical competitive analysis

Explore the latest publications and patents granted to Par Pharmaceutical, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Par Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 8, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Par Pharmaceutical
IPR2018-01550	Aug 21, 2018	PAR PHARMACEUTICAL	HORIZON THERAPEUTICS	Terminated-Settled
IPR2017-01768	Jul 13, 2017	PAR PHARMACEUTICAL	HORIZON THERAPEUTICS	Terminated-Settled
IPR2017-01769	Jul 13, 2017	PAR PHARMACEUTICAL	HORIZON THERAPEUTICS	Terminated-Settled
IPR2017-01767	Jul 13, 2017	PAR PHARMACEUTICAL	HORIZON THERAPEUTICS	Terminated-Settled
IPR2017-01557	Jun 9, 2017	PAR PHARMACEUTICAL	MONOSOL RX	Institution Denied
IPR2017-01292	Apr 18, 2017	PAR PHARMACEUTICAL	SUMITOMO DAINIPPON PHARMA	Terminated-Settled
IPR2016-01479	Jul 22, 2016	PAR PHARMACEUTICAL	NOVARTIS	Final Written Decision
IPR2016-01059	May 17, 2016	PAR PHARMACEUTICAL	NOVARTIS	Institution Denied
IPR2016-00078	Oct 26, 2015	PAR PHARMACEUTICAL	NOVARTIS	Institution Denied
IPR2016-00084	Oct 26, 2015	PAR PHARMACEUTICAL	NOVARTIS	Final Written Decision